• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于心脏临床试验的系统评价。

A systematic review of cardiac clinical trials.

作者信息

Rodero Cristobal, Baptiste Tiffany M G, Barrows Rosie K, Keramati Hamed, Sillett Charles P, Strocchi Marina, Lamata Pablo, Niederer Steven A

机构信息

Cardiac Electro-Mechanics Research Group (CEMRG), National Heart and Lung Institute, Imperial College London, London, United Kingdom.

Cardiac Electro-Mechanics Research Group (CEMRG), Department of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom.

出版信息

Prog Biomed Eng (Bristol). 2023 Jul 1;5(3):032004. doi: 10.1088/2516-1091/acdc71. Epub 2023 Jun 22.

DOI:10.1088/2516-1091/acdc71
PMID:37360227
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10286106/
Abstract

Computational models of the heart are now being used to assess the effectiveness and feasibility of interventions through clinical trials (ISCTs). As the adoption and acceptance of ISCTs increases, best practices for reporting the methodology and analysing the results will emerge. Focusing in the area of cardiology, we aim to evaluate the types of ISCTs, their analysis methods and their reporting standards. To this end, we conducted a systematic review of cardiac ISCTs over the period of 1 January 2012-1 January 2022, following the preferred reporting items for systematic reviews and meta-analysis (PRISMA). We considered cardiac ISCTs of human patient cohorts, and excluded studies of single individuals and those in which models were used to guide a procedure without comparing against a control group. We identified 36 publications that described cardiac ISCTs, with most of the studies coming from the US and the UK. In of the studies, a validation step was performed, although the specific type of validation varied between the studies. ANSYS FLUENT was the most commonly used software in of ISCTs. The specific software used was not reported in of the studies. Unlike clinical trials, we found a lack of consistent reporting of patient demographics, with of the studies not reporting them. Uncertainty quantification was limited, with sensitivity analysis performed in only of the studies. In of the ISCTs, no link was provided to provide easy access to the data or models used in the study. There was no consistent naming of study types with a wide range of studies that could potentially be considered ISCTs. There is a clear need for community agreement on minimal reporting standards on patient demographics, accepted standards for ISCT cohort quality control, uncertainty quantification, and increased model and data sharing.

摘要

心脏的计算模型目前正被用于通过临床试验(ISCTs)评估干预措施的有效性和可行性。随着ISCTs的采用和接受程度不断提高,报告方法和分析结果的最佳实践将会出现。聚焦于心脏病学领域,我们旨在评估ISCTs的类型、其分析方法及其报告标准。为此,我们按照系统评价和荟萃分析的首选报告项目(PRISMA),对2012年1月1日至2022年1月1日期间的心脏ISCTs进行了系统评价。我们考虑了人类患者队列的心脏ISCTs,并排除了对个体的研究以及那些使用模型指导手术但未与对照组进行比较的研究。我们确定了36篇描述心脏ISCTs的出版物,其中大部分研究来自美国和英国。在一些研究中进行了验证步骤,尽管不同研究之间验证的具体类型有所不同。ANSYS FLUENT是大多数ISCTs中最常用的软件。在一些研究中未报告所使用的具体软件。与临床试验不同,我们发现患者人口统计学信息的报告缺乏一致性,有一些研究未报告这些信息。不确定性量化有限,只有一些研究进行了敏感性分析。在一些ISCTs中,未提供链接以便轻松访问研究中使用的数据或模型。对于研究类型没有一致的命名,有广泛的研究可能被视为ISCTs。显然需要就患者人口统计学的最低报告标准、ISCT队列质量控制的公认标准、不确定性量化以及增加模型和数据共享达成社区共识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a0/10286106/0766b2425afe/prgbacdc71f7_lr.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a0/10286106/89b68003fa2d/prgbacdc71f1_lr.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a0/10286106/307809a9a126/prgbacdc71f2_lr.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a0/10286106/cd951829ea52/prgbacdc71f3_lr.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a0/10286106/8d68afc2e6d6/prgbacdc71f4_lr.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a0/10286106/e384dcdd205d/prgbacdc71f5_lr.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a0/10286106/6f49d0768a06/prgbacdc71f6_lr.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a0/10286106/0766b2425afe/prgbacdc71f7_lr.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a0/10286106/89b68003fa2d/prgbacdc71f1_lr.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a0/10286106/307809a9a126/prgbacdc71f2_lr.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a0/10286106/cd951829ea52/prgbacdc71f3_lr.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a0/10286106/8d68afc2e6d6/prgbacdc71f4_lr.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a0/10286106/e384dcdd205d/prgbacdc71f5_lr.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a0/10286106/6f49d0768a06/prgbacdc71f6_lr.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78a0/10286106/0766b2425afe/prgbacdc71f7_lr.jpg

相似文献

1
A systematic review of cardiac clinical trials.一项关于心脏临床试验的系统评价。
Prog Biomed Eng (Bristol). 2023 Jul 1;5(3):032004. doi: 10.1088/2516-1091/acdc71. Epub 2023 Jun 22.
2
Credibility assessment of in silico clinical trials for medical devices.医疗器械计算机模拟临床试验的可信度评估
PLoS Comput Biol. 2024 Aug 8;20(8):e1012289. doi: 10.1371/journal.pcbi.1012289. eCollection 2024 Aug.
3
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Toward trustworthy medical device clinical trials: a hierarchical framework for establishing credibility and strategies for overcoming key challenges.迈向值得信赖的医疗器械临床试验:建立可信度的分层框架及克服关键挑战的策略
Front Med (Lausanne). 2024 Aug 12;11:1433372. doi: 10.3389/fmed.2024.1433372. eCollection 2024.
6
A risk and credibility framework for in silico clinical trials of medical devices.医疗器械计算机模拟临床试验的风险与可信度框架。
Comput Methods Programs Biomed. 2023 Dec;242:107813. doi: 10.1016/j.cmpb.2023.107813. Epub 2023 Sep 14.
7
Economic impact of industry-sponsored clinical trials of pharmaceutical products in Austria.奥地利制药产品产业资助临床试验的经济影响。
J Med Econ. 2020 Jun;23(6):566-574. doi: 10.1080/13696998.2020.1728977. Epub 2020 Mar 4.
8
9
10
The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.综合护理路径在医疗环境中对成人和儿童的有效性:一项系统评价。
JBI Libr Syst Rev. 2009;7(3):80-129. doi: 10.11124/01938924-200907030-00001.

引用本文的文献

1
Cardiac digital twins: a tool to investigate the function and treatment of the diabetic heart.心脏数字孪生体:一种用于研究糖尿病性心脏功能与治疗的工具。
Cardiovasc Diabetol. 2025 Jul 18;24(1):293. doi: 10.1186/s12933-025-02839-w.
2
Computational modelling of biological systems now and then: revisiting tools and visions from the beginning of the century.生物系统计算建模的今昔:回顾本世纪初以来的工具与愿景
Philos Trans A Math Phys Eng Sci. 2025 May 8;383(2296):20230384. doi: 10.1098/rsta.2023.0384.
3
Mechanistic insights into effects of the cardiac myosin activator omecamtiv mecarbil from mechanokinetic modelling.

本文引用的文献

1
The Global Burden of Cardiovascular Diseases and Risk: A Compass for Future Health.心血管疾病及其风险的全球负担:未来健康指南。
J Am Coll Cardiol. 2022 Dec 20;80(25):2361-2371. doi: 10.1016/j.jacc.2022.11.005. Epub 2022 Nov 9.
2
Credibility assessment of patient-specific computational modeling using patient-specific cardiac modeling as an exemplar.以患者特定心脏建模为例评估患者特异性计算建模的可信度。
PLoS Comput Biol. 2022 Oct 10;18(10):e1010541. doi: 10.1371/journal.pcbi.1010541. eCollection 2022 Oct.
3
The health digital twin to tackle cardiovascular disease-a review of an emerging interdisciplinary field.
基于机械动力学模型对心肌肌球蛋白激活剂奥米卡替麦卡比效应的机制性见解
Front Physiol. 2025 Apr 17;16:1576245. doi: 10.3389/fphys.2025.1576245. eCollection 2025.
4
Artificial intelligence in heart valve disease: diagnosis, innovation and treatment. A state-of-the-art review.人工智能在心脏瓣膜疾病中的应用:诊断、创新与治疗。一篇最新综述。
Br J Cardiol. 2024 Aug 6;31(3):031. doi: 10.5837/bjc.2024.031. eCollection 2024.
5
Building Digital Twins for Cardiovascular Health: From Principles to Clinical Impact.构建心血管健康的数字孪生体:从原理到临床影响。
J Am Heart Assoc. 2024 Oct;13(19):e031981. doi: 10.1161/JAHA.123.031981. Epub 2024 Aug 1.
6
Tapping into Nature's Arsenal: Harnessing the Potential of Natural Antioxidants for Human Health and Disease Prevention.挖掘大自然的宝库:利用天然抗氧化剂对人类健康和疾病预防的潜力。
Foods. 2024 Jun 25;13(13):1999. doi: 10.3390/foods13131999.
7
Advancing clinical translation of cardiac biomechanics models: a comprehensive review, applications and future pathways.推进心脏生物力学模型的临床转化:全面综述、应用及未来路径
Front Phys. 2023 Nov 14;11:1306210. doi: 10.3389/fphy.2023.1306210.
8
Constructing bilayer and volumetric atrial models at scale.构建大规模的双层和三维心房模型。
Interface Focus. 2023 Dec 15;13(6):20230038. doi: 10.1098/rsfs.2023.0038. eCollection 2023 Dec 6.
用于应对心血管疾病的健康数字孪生——新兴跨学科领域综述
NPJ Digit Med. 2022 Aug 26;5(1):126. doi: 10.1038/s41746-022-00640-7.
4
Toward A Regulatory Pathway for the Use of in Silico Trials in the CE Marking of Medical Devices.迈向在医疗器械 CE 标志中使用计算机模拟试验的监管途径。
IEEE J Biomed Health Inform. 2022 Nov;26(11):5282-5286. doi: 10.1109/JBHI.2022.3198145. Epub 2022 Nov 10.
5
Race/ethnicity reporting and representation in US clinical trials: a cohort study.美国临床试验中的种族/族裔报告与代表性:一项队列研究。
Lancet Reg Health Am. 2022 Jul;11. doi: 10.1016/j.lana.2022.100252. Epub 2022 Apr 10.
6
Impact of anatomical reverse remodelling in the design of optimal quadripolar pacing leads: A computational study.解剖学逆向重塑对最佳四极起搏导线设计的影响:一项计算研究。
Comput Biol Med. 2022 Jan;140:105073. doi: 10.1016/j.compbiomed.2021.105073. Epub 2021 Nov 25.
7
Clinically-Driven Virtual Patient Cohorts Generation: An Application to Aorta.临床驱动的虚拟患者队列生成:在主动脉方面的应用
Front Physiol. 2021 Sep 1;12:713118. doi: 10.3389/fphys.2021.713118. eCollection 2021.
8
Sex Differences in Drug-Induced Arrhythmogenesis.药物诱导的心律失常发生中的性别差异。
Front Physiol. 2021 Aug 19;12:708435. doi: 10.3389/fphys.2021.708435. eCollection 2021.
9
A bi-atrial statistical shape model for large-scale in silico studies of human atria: Model development and application to ECG simulations.用于人类心房大规模计算机模拟研究的双心房统计形状模型:模型开发及其在心电图模拟中的应用。
Med Image Anal. 2021 Dec;74:102210. doi: 10.1016/j.media.2021.102210. Epub 2021 Aug 10.
10
Hemodynamic performance of tissue-engineered vascular grafts in Fontan patients.法洛四联症患者组织工程血管移植物的血流动力学性能
NPJ Regen Med. 2021 Jul 22;6(1):38. doi: 10.1038/s41536-021-00148-w.